Jean-Noël Fabiani-Salmon/LinkedIn
Oct 18, 2025, 05:11
From Mechanical Valves to TAVI: The Medical Innovation Journey
Jean-Noël Fabiani-Salmon, Emeritus Professor of Medicine at Paris Cité University, posted on LinkedIn:
”Mechanical valves require effective anticoagulant treatment to prevent thrombosis.
Alain Carpentier, who was still assistant head of clinic, proposed to use first porcine heterografts and then calf pericardium to replace the valves of the heart in order to treat patients who could not be anticoagulated and those in whom biological monitoring was problematic.
This technique has become the treatment of choice for severe valvular heart disease. It is also now applied to the TAVI technique… The incredible history of medicine.
Jean-Noël Fabiani-Salmon and Philippe Bercovici. Les Arènes.”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 14:17Maha Othman: Advancing Thrombosis and Hemostasis Research at ISTH 2026
-
Jul 8, 2026, 14:07Zain Khalpey: Atrial Fibrillation as the Hidden Driver of Preventable Ischemic Stroke
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis